Invesco Portfolio holdings
Invesco is an investment management company that launched the Invesco QQQ exchange-traded fund in 1999, back when it operated as Amvescap. Invesco QQQ tracks the Nasdaq-100 index of companies listed on Nasdaq. Invesco traces its roots to H. Lotery & Co., a UK advisory firm formed in 1935, and in 1978 Charles Brady and eight partners bought the money management arm of Citizens & Southern National Bank, then called INVESCO. It bought PowerShares Capital Management, sponsor of 36 exchange-traded funds, in 2006, and in 2007 it went back to the Invesco name and moved its legal home to Bermuda. Its 2009 purchase of Morgan Stanley's retail unit brought in Van Kampen Investments, and in 2019 it acquired OppenheimerFunds from Massachusetts Mutual Life Insurance Company. It serves retail and institutional investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$6.35B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$2.84B |
| 3 |
Arm
ARM
|
+$1.84B |
| 4 |
Lumentum
LITE
|
+$1.78B |
| 5 |
Teradyne
TER
|
+$1.57B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco NASDAQ 100 ETF
QQQM
|
+$2.26B |
| 2 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.2B |
| 3 |
Honeywell
HON
|
+$2.2B |
| 4 |
Dell
DELL
|
+$1.69B |
| 5 |
Insmed
INSM
|
+$744M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 44.02% |
| 2 | Consumer Discretionary | 9.38% |
| 3 | Communication Services | 9.23% |
| 4 | Industrials | 8.59% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3526
Sohu.com
SOHU
$344M
| $204K | ﹤0.01% |
16,799
-2,334
| -12% | -$33.5K |
2013 Q2
52 quarters
|
|
3527
FRP Holdings
FRPH
$360M
| $203K | ﹤0.01% |
+8,137
| New | +$184K |
2026 Q2
0 quarters
|
|
3528
InnovAge Holding
INNV
$1.25B
| $203K | ﹤0.01% |
+17,126
| New | +$140K |
2026 Q2
0 quarters
|
|
3529
NACCO Industries
NC
$264M
| $201K | ﹤0.01% |
4,023
-64
| -2% | -$3.21K |
2025 Q4
2 quarters
|
|
3530
Information Services Group
III
$295M
| $201K | ﹤0.01% |
48,909
+201
| +0.4% | +$841 |
2020 Q2
24 quarters
|
|
3531
Westrock Coffee
WEST
$970M
| $201K | ﹤0.01% |
24,759
+6,346
| +34% | +$45.5K |
2023 Q2
12 quarters
|
|
3532
iShares MSCI South Africa ETF
EZA
$439M
| $201K | ﹤0.01% |
3,174
-1,011
| -24% | -$69.2K |
2025 Q4
2 quarters
|
|
3533
Humacyte
HUMA
$114M
| $199K | ﹤0.01% |
255,534
+83,099
| +48% | +$77K |
2022 Q2
16 quarters
|
|
3534
LCNB Corp
LCNB
$284M
| $199K | ﹤0.01% |
11,329
+806
| +8% | +$13.4K |
2025 Q4
2 quarters
|
|
3535
abrdn World Healthcare Fund
THW
$519M
| $199K | ﹤0.01% |
14,840
+680
| +5% | +$8.55K |
2026 Q1
1 quarter
|
|
3536
American Battery Technology Co
ABAT
$202M
| $199K | ﹤0.01% |
70,221
-17,125
| -20% | -$54.8K |
2025 Q2
4 quarters
|
|
3537
Chegg
CHGG
$78M
| $196K | ﹤0.01% |
194,384
-101,652
| -34% | -$112K |
2016 Q1
41 quarters
|
|
3538
Lyell Immunopharma
LYEL
$271M
| $195K | ﹤0.01% |
+13,914
| New | +$252K |
2026 Q2
0 quarters
|
|
3539
Evolution Petroleum
EPM
$153M
| $192K | ﹤0.01% |
52,282
-8,031
| -13% | -$35.1K |
2023 Q2
12 quarters
|
|
3540
Xunlei
XNET
$226M
| $192K | ﹤0.01% |
34,324
-3,408
| -9% | -$19.7K |
2025 Q1
5 quarters
|
|
3541
Franklin Universal Trust
FT
$184M
| $192K | ﹤0.01% |
23,803
-271
| -1% | -$2.19K |
2025 Q3
3 quarters
|
|
3542
Next Technology
NXTT
$7.81M
| $192K | ﹤0.01% |
+1,727
| New | +$270K |
2026 Q2
0 quarters
|
|
3543
Atrium Therapeutics
RNA
$141M
| $191K | ﹤0.01% |
14,174
+3,981
| +39% | +$52K |
2026 Q1
1 quarter
|
|
3544
Tenax Therapeutics
TENX
$67M
| $191K | ﹤0.01% |
+13,096
| New | +$167K |
2026 Q2
0 quarters
|
|
3545
MediWound
MDWD
$179M
| $189K | ﹤0.01% |
+12,861
| New | +$204K |
2026 Q2
0 quarters
|
|
3546
Zura Bio
ZURA
$371M
| $189K | ﹤0.01% |
+32,029
| New | +$153K |
2026 Q2
0 quarters
|
|
3547
Niagen Bioscience
NAGE
$184M
| $187K | ﹤0.01% |
58,596
+15,109
| +35% | +$61.3K |
2024 Q2
8 quarters
|
|
3548
Strata Critical Medical Inc
SRTA
$393M
| $186K | ﹤0.01% |
35,300
+8,166
| +30% | +$43K |
2022 Q2
16 quarters
|
|
3549
Prelude Therapeutics
PRLD
$327M
| $185K | ﹤0.01% |
+34,742
| New | +$151K |
2026 Q2
0 quarters
|
|
3550
eGain
EGAN
$154M
| $184K | ﹤0.01% |
29,205
+1,847
| +7% | +$13.5K |
2025 Q4
2 quarters
|
|
Similar funds
Invesco's Q2 2026 Portfolio in Review
As of Q2 2026, Invesco held 3,969 positions worth $1.26T, up 23% from $1.02T the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Invesco's Q2 2026 filing shows 214 new, 1,806 increased, 1,705 reduced and 150 closed positions. Its largest new stake was Honeywell Aerospace: 12,884,435 shares worth $2.85B. The largest sale was Invesco NASDAQ 100 ETF, an estimated $2.26B.
By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 35% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Invesco's largest Q2 2026 buy was Honeywell Aerospace: 12,884,435 shares worth $2.85B.
- Invesco added most to Sandisk in Q2 2026, an estimated $6.35B increase.
- Invesco's biggest Q2 2026 reduction was Invesco NASDAQ 100 ETF, cutting an estimated $2.26B.
- Invesco fully exited Coterra Energy in Q2 2026, selling an estimated $394M.
- Invesco's ten largest holdings make up 29% of its $1.26T portfolio in Q2 2026.
- Invesco opened 214 new positions and closed 150 in Q2 2026.
- Invesco's portfolio value rose 23% quarter-over-quarter to $1.26T.
Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.